Who is sponsoring NCT03910881?

NCT03910881 is sponsored by University of Alabama at Birmingham.

What drugs are being tested in NCT03910881?

Interventions in NCT03910881: Open-platform patient support system (PSS) app.

What condition does NCT03910881 study?

NCT03910881 studies Cystic Fibrosis.

Is NCT03910881 still recruiting?

NCT03910881 is currently completed. Last updated 4 May 2021.

Last reviewed 2021-05-04 · How we verify

NCT03910881

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Technology-enabled Patient Support System for Self-management of CF

Completed NA Last updated 4 May 2021

What this trial tests

NA trial testing Open-platform patient support system (PSS) app in Cystic Fibrosis in 40 participants. Completed in 31 January 2021.

Timeline

18 February 2020

Primary endpoint
31 January 2021

31 January 2021

Quick facts

Lead sponsor	University of Alabama at Birmingham
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	40
Start date	18 February 2020
Primary completion	31 January 2021
Estimated completion	31 January 2021
Sites	1 location across United States

Drugs / interventions tested

Open-platform patient support system (PSS) app

Conditions studied

Cystic Fibrosis — all drugs for Cystic Fibrosis →

Sponsor

University of Alabama at Birmingham

Who can join

15 and older, any sex, with Cystic Fibrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project will test a technology-enabled patient support system (PSS) as a self-management tool for children with CF and their family caregivers.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Sharing Patient-Controlled Real-World Data Through the Application of the Theory of Commons: Action Research Case Study.
Hager A, Lindblad S, Brommels M, Salomonsson S, et al · · 2021 · cited 11× · PMID 33464212 · DOI 10.2196/16842
A Mobile Health Platform for Self-Management of Pediatric Cystic Fibrosis: Qualitative Study of Adaptation to Stakeholder Needs and Integration in Clinical Settings.
Rutland SB, Bergquist RP, Hager A, Geurs R, et al · · 2021 · cited 9× · PMID 33496667 · DOI 10.2196/19413

Verify or expand the search:

Other recruiting trials for Cystic Fibrosis

Currently open trials in the same condition.

NCT07437105 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants · Phase 1 · recruiting
NCT07283770 — Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants · Phase 1 · recruiting
NCT07274631 — A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine · recruiting
NCT06810167 — Assessing Tenapanor as a Treatment of CF-related Constipation. · Phase 3 · recruiting
NCT06962852 — A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI · Phase 1, PHASE2 · active not recruiting

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · NA · not yet recruiting
NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine · Phase 2 · not yet recruiting
NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03910881 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
Last refreshed: 4 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03910881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing